Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01801098
Other study ID # HV-interval prior TAVI
Secondary ID
Status Completed
Phase N/A
First received February 6, 2013
Last updated November 12, 2013
Start date December 2012
Est. completion date November 2013

Study information

Verified date November 2013
Source Heinrich-Heine University, Duesseldorf
Contact n/a
Is FDA regulated No
Health authority Germany: Ethic Committee
Study type Observational

Clinical Trial Summary

The development of a high grade AV-block is a frequent complication associated with transcatheter aortic valve implantation (TAVI). Patients who were suitable for TAVI will be enrolled in this study. The HV-interval will be determined before and immediately after implantation.

The hypothesis is that a prolonged HV-interval is associated with a high rate of complete AV-block following TAVI.


Recruitment information / eligibility

Status Completed
Enrollment 25
Est. completion date November 2013
Est. primary completion date November 2013
Accepts healthy volunteers No
Gender Both
Age group 18 Years and older
Eligibility Inclusion Criteria:

- symptomatic aortic valve stenosis

- patients screened for TAVI

- written informed consent

Exclusion Criteria:

- unconsciousness, not able to consent

- < 18 years

- permanent pacemaker

Study Design

Observational Model: Cohort


Related Conditions & MeSH terms


Locations

Country Name City State
Germany Division of Cardiology, Pulmonary Diseases, Vascular Medicine, University Hospital Duesseldorf Duesseldorf NRW

Sponsors (1)

Lead Sponsor Collaborator
Klinik für Kardiologie, Pneumologie und Angiologie

Country where clinical trial is conducted

Germany, 

Outcome

Type Measure Description Time frame Safety issue
Other cardiovascular mortality 1 month, 6 months and 12 months Yes
Primary Determination of HV interval HV-interval will be determined by a 5F quadripolar electrode catheter with a CRD-2 curve configuration. Intracardiac signals will be assessed and determined before and after implantation. Changes in Baseline to 24 hours Yes
Secondary AV-block development after 1 month, 6 months and 12 months 1 month, 6 months and 12 months Yes

External Links